Alterations in intestinal Proteobacteria and antimicrobial resistance gene burden in individuals administered microbial ecosystem therapeutic (MET-2) for recurrent Clostridioides difficile infection
A. M. Rooney, K. Cochrane, S. Fedsin, S. Yao, S. Anwer, S. Dehmiwal, S. Hota, S. Poutanen, E. Allen-Vercoe, B. Coburn
This study compares the effects of MET-2 and FMT on reducing Proteobacteria and antimicrobial resistance genes in patients with recurrent C. difficile infection.
bioRxiv · Nov 4, 2022 · PreprintMicrobiology